The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...

AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...

When Pascal Soriot flew in to speak at the Boao Forum in China this year, many expected him to keep a low profile. With ...

When Pascal Soriot flew in to speak at the Boao Forum in China this year, many expected him to keep a low profile. With ...

Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with an investment of Rs166 ...

Global bio-pharmaceutical company AstraZeneca has established its state-of-the-art Global Hub in Bengaluru investing Rs 166 ...

Bengaluru: Global biopharmaceutical company AstraZeneca is investing Rs166 crore to expand its Bengaluru operations, creating ...

BENGALURU: Biopharmaceutical company AstraZeneca on Thursday announced the expansion of its global hub in Bengaluru with Rs ...

AstraZeneca invests Rs 166 crore in a new Bengaluru Global Hub focused on AI-driven healthcare solutions, creating 400 new ...

This expansion will support the company’s AI-powered innovation across R&D, global business services, IT, and digital health.

AstraZeneca has launched a Phase I clinical study titled An Open-label, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 Followi ...

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...